Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Caretek Medical is a UK-based medical technology company that developed the ImplaVax needle-free drug delivery platform. The ImplaVax system enables the administration of vaccines and therapeutics as solid-dose formulations, which are delivered subcutaneously or intramuscularly using a specialized applicator. This technology eliminates the need for needles, reduces the requirement for cold-chain storage, and can potentially enhance the immune response to vaccines. The platform is designed to be compatible with a wide range of biologics and small molecules, offering a versatile solution for drug delivery. In June 2022, the company was acquired by Nuance Pharma, a biopharmaceutical company focused on the China and Asia-Pacific markets, to integrate the ImplaVax platform into their respiratory and pain management portfolios.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Caretek Medical.